Skip to main content

Table 1 Baseline Characteristics Of Patients Studied: Number (%) or Mean (SD) Values Are Shown

From: Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

 

All Patients

Patients Followed Over Three Or More Years

Patients Followed Less Than Three Years

(n = 1693)

(n = 752)

(n = 941)

Gender, n (%)

Female

1262 (75%)

579 (77%)

683 (73%)

Male

412 (24%)

165 (22%)

247 (26%)

Missing

19 (1%)

8 (1%)

11 (1%)

Ethnicity, n (%)

Caucasian

1134 (67%)

540 (72%)

594 (63%)

Black African/Caribbean

209 (12%)

100 (13%)

109 (11%)

Asian/other background

128 (8%)

52 (7%)

76 (8%)

Not Stated

79 (5%)

27 (4%)

52 (6%)

Missing

143 (8%)

33 (4%)

110 (12%)

Age (years)

 

55 (16)

55 (15)

55 (14.7)

Disease Duration (years)

 

11 (10)

10 (10)

10 (9.7)

Tender Joint Counts (28 joints)

 

5.0 (6.6)

4.8 (6.0)

5.2 (6.5)

Swollen joint Counts (28 joints)

 

2.9 (4.7)

3.2 (3.9)

3.3 (4.3)

Erythrocyte Sedimentation Rate (mm/hr)

 

22 (21)

22 (21)

21.5 (22)

Patient Global Assessment (mm)

 

46 (28)

44 (27)

45 (28)

DAS28

 

3.83 (1.63)

3.79 (1.50)

3.85 (1.62)

Health Assessment Questionnaire

 

1.18 (0.83)

1.22 (0.86)

1.18 (0.83)

EQ5D-3 L

 

0.53 (0.34)

0.52 (0.33)

0.53 (0.34)